These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9279168)

  • 1. Bisphosphonates in osteogenesis imperfecta.
    Shaw NJ
    Arch Dis Child; 1997 Jul; 77(1):92-3. PubMed ID: 9279168
    [No Abstract]   [Full Text] [Related]  

  • 2. Bisphosphonate therapy for osteogenesis imperfecta.
    Dwan K; Phillipi CA; Steiner RD; Basel D
    Cochrane Database Syst Rev; 2014 Jul; (7):CD005088. PubMed ID: 25054949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New uses of bisphosphonates: osteogenesis imperfecta.
    Devogelaer JP
    Curr Opin Pharmacol; 2002 Dec; 2(6):748-53. PubMed ID: 12482741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with bisphosphonates in osteogenesis imperfecta.
    Glorieux FH
    Pediatrics; 2007 Mar; 119 Suppl 2():S163-5. PubMed ID: 17332237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do bisphosphonates make children's bones better or brittle?
    Marini JC
    N Engl J Med; 2003 Jul; 349(5):423-6. PubMed ID: 12890840
    [No Abstract]   [Full Text] [Related]  

  • 6. Bisphosphonates in children with osteogenesis imperfecta may improve bone mineralization but not bone strength. Report of two patients.
    Roldán EJ; Pasqualini T; Plantalech L
    J Pediatr Endocrinol Metab; 1999; 12(4):555-9. PubMed ID: 10417973
    [No Abstract]   [Full Text] [Related]  

  • 7. Are drugs helpful in adults with osteogenesis imperfecta?
    Chevrel G; Meunier PJ
    Rev Rhum Engl Ed; 1997 May; 64(5):283-6. PubMed ID: 9190000
    [No Abstract]   [Full Text] [Related]  

  • 8. Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study.
    Sakkers R; Kok D; Engelbert R; van Dongen A; Jansen M; Pruijs H; Verbout A; Schweitzer D; Uiterwaal C
    Lancet; 2004 May; 363(9419):1427-31. PubMed ID: 15121405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of denosumab on the growing skeleton in osteogenesis imperfecta.
    Hoyer-Kuhn H; Semler O; Schoenau E
    J Clin Endocrinol Metab; 2014 Nov; 99(11):3954-5. PubMed ID: 25148238
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiological features of bisphosphonate therapy in children with osteogenesis imperfecta.
    Bin-Abbas BS; Al-Ashwal AA; Al-Zayed ZS; Sakati NA
    Saudi Med J; 2004 Nov; 25(11):1772-3. PubMed ID: 15573233
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical bone markers in the assessment and pamidronate treatment of children and adolescents with osteogenesis imperfecta.
    Aström E; Magnusson P; Eksborg S; Söderhäll S
    Acta Paediatr; 2010 Dec; 99(12):1834-40. PubMed ID: 20726960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate treatment of children and adults with osteogenesis imperfecta: unanswered questions.
    Brizola E; Shapiro JR
    Calcif Tissue Int; 2015 Aug; 97(2):101-3. PubMed ID: 26071113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Osteogenesis imperfecta and bisphosphonates].
    Forin V
    Arch Pediatr; 2005 Jun; 12(6):688-90. PubMed ID: 15904772
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of osteogenesis imperfecta with bisphosphonates].
    Tau C
    Medicina (B Aires); 2007; 67(4):389-95. PubMed ID: 17891938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bisphosphonate treatment of children and adolescents].
    Illum NO
    Ugeskr Laeger; 2003 Jan; 165(5):454-6. PubMed ID: 12599842
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone densitometry in pediatric patients treated with pamidronate.
    Grissom LE; Kecskemethy HH; Bachrach SJ; McKay C; Harcke HT
    Pediatr Radiol; 2005 May; 35(5):511-7. PubMed ID: 15655696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Bisphosphonates on Bone Mineral Density and Fracture Rate in Patients With Osteogenesis Imperfecta: A Systematic Review and Meta-analysis.
    Shi CG; Zhang Y; Yuan W
    Am J Ther; 2016; 23(3):e894-904. PubMed ID: 25844482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biphosphonates and osteogenesis imperfecta in children].
    Gandon-Laloum S
    Arch Pediatr; 2009 Jul; 16(7):1085-9. PubMed ID: 19423303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates for the prevention of fractures in osteogenesis imperfecta: meta-analysis of placebo-controlled trials.
    Hald JD; Evangelou E; Langdahl BL; Ralston SH
    J Bone Miner Res; 2015 May; 30(5):929-33. PubMed ID: 25407702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate therapy and osteogenesis imperfecta: The lived experience of children and their mothers.
    Wiggins S; Kreikemeier R
    J Spec Pediatr Nurs; 2017 Oct; 22(4):. PubMed ID: 28876506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.